Lakeland Pathologists, PA

Lakeland Pathologists, PA was paid $4.56M by Medicaid between Jan 2018 and Dec 2024, across 172 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 9.3% of everything it billed.

33Billing provider infoLAKELAND PATHOLOGISTS, PA
LAKELAND, FL 33801

33aNPI1649220872assigned 05/10/2006

33bProvider typeAnatomic Pathology & Clinical Pathology Physician

28Total paid$4.56M

24GClaims1,808,922

24DCodes billed172

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida

Rank by total paid#6 of 207

Median peer was paid$39K

This provider vs. median116×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	68,842	$64K
2019	248,324	$486K
2020	225,218	$702K
2021	305,451	$676K
2022	339,266	$1.07M
2023	373,735	$1.04M
2024incomplete	248,086	$525K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	9.3%	36,160	32,403	$422K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	8.5%	24,740	23,582	$389K
88305	Level IV - Surgical pathology, gross and microscopic examination	8.5%	11,060	9,423	$386K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	7.3%	10,757	10,286	$333K
82565		5.5%	80,213	66,057	$253K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	5.5%	182,894	115,852	$252K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	5.4%	11,621	11,100	$246K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	4.6%	68,628	43,035	$210K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	4.0%	15,515	14,435	$183K
80051		2.5%	73,944	63,577	$116K
80053	Comprehensive metabolic panel	2.4%	54,544	36,147	$107K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.9%	16,162	15,787	$86K

160 more codes

88307		1.8%	1,411	$84K
80048	Basic metabolic panel (calcium, ionized)	1.8%	60,873	$81K
82947		1.5%	69,938	$70K
84484		1.4%	48,745	$63K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.3%	14,687	$60K
87486		1.2%	14,429	$55K
87086	Culture, bacterial; quantitative colony count, urine	1.2%	32,303	$53K
81001		1.1%	64,525	$50K
87581		1.1%	14,439	$49K
87430		1.1%	13,034	$49K
81003		1.0%	81,765	$47K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	8,003	$43K
83690		<1%	42,908	$35K
80076		<1%	49,256	$34K
83735		<1%	45,144	$33K
84443	Thyroid stimulating hormone (TSH)	<1%	12,822	$32K
84703		<1%	46,044	$31K
87040		<1%	19,628	$30K
82550		<1%	7,403	$30K
84702		<1%	9,943	$25K
84520		<1%	75,573	$24K
82140		<1%	3,514	$24K
87420		<1%	11,550	$23K
86141		<1%	7,176	$21K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,245	$20K
83605		<1%	14,949	$19K
87077		<1%	14,979	$19K
88342		<1%	2,513	$18K
87070		<1%	16,293	$17K
82310		<1%	4,033	$16K
80061	Lipid panel	<1%	8,690	$16K
85610		<1%	39,929	$16K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	553	$15K
84100		<1%	20,541	$15K
85027		<1%	25,490	$14K
87631		<1%	750	$14K
82607		<1%	3,298	$13K
82247		<1%	10,776	$12K
82330		<1%	5,786	$12K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	826	$12K
84481		<1%	3,275	$11K
85730		<1%	22,828	$11K
83036	Hemoglobin; glycosylated (A1C)	<1%	10,707	$11K
82728		<1%	4,735	$11K
80047		<1%	1,260	$10K
82150		<1%	1,696	$9K
87653		<1%	1,728	$9K
87808		<1%	7,483	$9K
87205		<1%	21,990	$9K
87186		<1%	10,669	$8K
86803		<1%	2,547	$8K
85055		<1%	2,047	$8K
85520		<1%	6,274	$7K
85379		<1%	12,165	$7K
84112		<1%	1,727	$7K
87015		<1%	2,677	$7K
82805		<1%	293	$6K
88304		<1%	519	$6K
87507		<1%	1,115	$6K
82553		<1%	6,342	$6K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	282	$5K
85576		<1%	2,470	$5K
82248		<1%	4,057	$5K
80202		<1%	2,825	$5K
87427		<1%	1,837	$4K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,076	$4K
84132		<1%	12,125	$4K
82948		<1%	6,270	$4K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,843	$4K
84439		<1%	4,740	$3K
87210		<1%	6,510	$3K
85651		<1%	8,178	$3K
87496		<1%	243	$3K
80074		<1%	256	$3K
83880		<1%	9,761	$3K
86140		<1%	9,488	$3K
82374		<1%	5,226	$2K
83615		<1%	3,680	$2K
80164		<1%	873	$2K
85045		<1%	5,671	$2K
87075		<1%	2,057	$2K
82746		<1%	1,111	$2K
87102		<1%	1,412	$2K
87046		<1%	1,937	$2K
84466		<1%	1,061	$2K
87116		<1%	1,005	$2K
86762		<1%	956	$1K
85018		<1%	7,721	$1K
87045		<1%	1,266	$1K
82570		<1%	2,411	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	101	$1K
86769		<1%	312	$1K
87340		<1%	1,481	$1K
0352U		<1%	578	$1K
82010		<1%	2,167	$1K
87480		<1%	584	$1K
82945		<1%	696	$1K
87081		<1%	1,899	$1K
83540		<1%	1,877	$1K
84156		<1%	3,236	$1K
84145		<1%	8,972	$986.07
86480		<1%	59	$924.77
85014		<1%	7,331	$885.36
84295		<1%	5,577	$880.62
82435		<1%	5,235	$875.67
87154		<1%	53	$779.35
86308		<1%	1,355	$758.69
87206		<1%	1,005	$709.58
87660		<1%	622	$599.09
85380		<1%	987	$591.60
84478		<1%	1,024	$501.19
87510		<1%	582	$489.72
84134		<1%	247	$433.56
87147		<1%	1,249	$430.18
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	963	$411.85
83930		<1%	424	$392.40
0240U		<1%	119	$366.56
88300		<1%	54	$330.22
88112		<1%	50	$275.26
86900		<1%	1,149	$270.90
0353U		<1%	548	$255.13
89051		<1%	640	$253.79
86780		<1%	649	$243.08
82657		<1%	25	$213.40
80329		<1%	138	$210.00
84157		<1%	742	$200.64
86901		<1%	1,134	$199.98
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,117	$174.50
87899		<1%	221	$169.34
82533		<1%	55	$151.64
84550		<1%	460	$150.95
81025		<1%	394	$136.05
86706		<1%	192	$133.36
85384		<1%	212	$129.80
80179		<1%	1,128	$122.90
80050	General health panel	<1%	444	$114.64
80143		<1%	1,195	$90.06
87400		<1%	120	$85.18
80069		<1%	90	$81.89
80185		<1%	35	$59.16
83520		<1%	36	$47.62
87905		<1%	5,145	$36.72
86592		<1%	279	$36.52
84300		<1%	69	$30.41
83935		<1%	32	$29.14
85347		<1%	33	$20.15
85652		<1%	67	$15.68
82274		<1%	28	$12.66
86665		<1%	17	$12.10
86850		<1%	16	$8.74
86664		<1%	17	$8.52
86663		<1%	32	$6.81
85007		<1%	14	$1.71
87150		0%	1,064	$0.00
82652		0%	14	$0.00
87634		0%	14	$0.00
84165		0%	20	$0.00
87632		0%	12	$0.00
87493		0%	43	$0.00
82077		0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCUFFE, COLLEEN (CEO)